
Prism Medico & Pharmacy Ltd is Rated Sell
2026-07-17 10:10:23Prism Medico & Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 July 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Prism Medico & Pharmacy Ltd is Rated Sell
2026-07-02 10:10:30Prism Medico & Pharmacy Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Prism Medico & Pharmacy Ltd is Rated Sell
2026-06-18 10:10:04Prism Medico & Pharmacy Ltd is rated Sell by MarketsMOJO. This rating was last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 June 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Prism Medico & Pharmacy Ltd is Rated Sell
2026-05-21 10:10:42Prism Medico & Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Prism Medico & Pharmacy Ltd is Rated Sell
2026-05-08 10:10:44Prism Medico & Pharmacy Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Prism Medico & Pharmacy Ltd Valuation Shifts Signal Price Attractiveness Change
2026-05-06 08:00:30Prism Medico & Pharmacy Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a subtle but meaningful change in price attractiveness. This reclassification comes amid mixed financial metrics and a volatile market backdrop, prompting investors to reassess the stock’s appeal relative to its peers and historical benchmarks.
Read full news article
Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34.49
2026-04-29 09:43:32Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a new 52-week high of Rs 34.49 on 29 Apr 2026, marking a remarkable 128.87% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages.
Read full news article
Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34
2026-04-27 14:37:25With a remarkable 131.29% gain over the past year, Prism Medico & Pharmacy Ltd surged to a fresh 52-week high of Rs 34 on 27 Apr 2026, outpacing the Sensex which declined by 2.48% during the same period. This milestone caps a four-day winning streak that has propelled the stock up by 9.47%, underscoring a strong momentum that is supported by a confluence of technical indicators.
Read full news article
Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 33.65
2026-04-24 09:42:50Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 33.65 on 24 Apr 2026, marking a remarkable 126.56% gain over the past year. This rally stands in stark contrast to the broader market’s decline, with the Sensex down 3.48% over the same period, underscoring the stock’s strong momentum and technical resilience.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13-Jul-2026 | Source : BSEDear Sir/ Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find the attached certificate issued by Registrar and Share Transfer Agent (RTA) for the quarter ended on 30th June 2026. Kindly take the same on record and oblige. Thank you.
Compliance-57 (5) : intimation after the end of quarter
06-Jul-2026 | Source : BSEDear Sir/Madam Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the attached intimation for your reference and record. Thanking you.
Compliance-57 (4) : Prior intimation to the beginning of the quarter
30-Jun-2026 | Source : BSEPursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find the attached intimation letter. You are requested to Kindly take the same on record and oblige.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






